U.S. Backs Drug Firms in Lawsuit Over Prices

The Obama administration, following a lengthy internal debate, has unexpectedly come down on the side of pharmaceutical companies that are accused of overcharging public hospitals and clinics that care for large numbers of poor people, Robert Pear of the New York Times reports.

Read Pear’s full story.